The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results from phase II study of combination of hyper-CVAD (HCVAD) with ponatinib in frontline therapy of patients (pts) with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).
 
Koji Sasaki
No Relationships to Disclose
 
Hagop M. Kantarjian
Research Funding - Amgen (Inst); ARIAD (Inst); Bristol-Myers Squibb (Inst); Delta-Fly Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Farhad Ravandi
Honoraria - Amgen; Pfizer; Seagen; Sunesis Pharmaceuticals
Consulting or Advisory Role - Amgen; Seagen; Sunesis Pharmaceuticals
Research Funding - Amgen; Bristol-Myers Squibb; Merck; Seagen; Sunesis Pharmaceuticals
 
Deborah A. Thomas
No Relationships to Disclose
 
Jorge E. Cortes
Consulting or Advisory Role - Ambit BioSciences; Amphivena Therapeutics; ARIAD; Astellas Pharma; BiolineRx; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Ambit BioSciences (Inst); ARIAD (Inst); Arog (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Teva (Inst)
 
Naveen Pemmaraju
Honoraria - Incyte; LFB Biotechnologies; Novartis
Consulting or Advisory Role - Incyte; LFB Biotechnologies; Novartis
Research Funding - Incyte; Novartis; Stemline Therapeutics
 
Tapan M. Kadia
No Relationships to Disclose
 
Nicholas James Short
No Relationships to Disclose
 
Ghayas C. Issa
No Relationships to Disclose
 
Rebecca S. Garris
No Relationships to Disclose
 
Vicky Jeanis
No Relationships to Disclose
 
H. Gal Moore
No Relationships to Disclose
 
Guillermo Garcia-Manero
No Relationships to Disclose
 
Gautam Borthakur
No Relationships to Disclose
 
William G. Wierda
No Relationships to Disclose
 
Evguenia Gachimova
No Relationships to Disclose
 
Susan Mary O'Brien
Honoraria - Celgene; Gilead Sciences; Janssen; Pfizer; Pharmacyclics; ProNAi; Regeneron
Consulting or Advisory Role - Amgen; Celgene; CLL Global Research Foundation
Research Funding - Acerta Pharma; Gilead Sciences; Regeneron
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Janssen; Regeneron
 
Elias Jabbour
Research Funding - Amgen (Inst); Novartis (Inst); Pfizer (Inst)